Thomas Schwarzl

Thomas Schwarzl

Auto-generated profile, based on publicly available information

Thomas Schwarzl

European Molecular Biology Laboratory (EMBL) , Meyerhofstrasse 1, 69117 Heidelberg

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 January 2018 in Nature Reviews Molecular Cell Biology
Verified
Journal Article
Closed access
PDF file
MHMatthias W. Hentze
Matthias W. Hentze
ACAlfredo Castello
Alfredo Castello
TSThomas Schwarzl
Thomas Schwarzl
Thomas PreissThomas Preiss
Thomas Preiss

24 November 2020 in Nature Reviews Genetics
Verified
Journal Article
Closed access
PDF file
FGFatima Gebauer
Fatima Gebauer
TSThomas Schwarzl
Thomas Schwarzl
JVJuan Valcárcel
Juan Valcárcel
MHMatthias W. Hentze
Matthias W. Hentze

3 December 2015 in Nature Communications
Verified
Journal Article
Open access
PDF file
BBBenedikt M. Beckmann
Benedikt M. Beckmann
RHRastislav Horos
Rastislav Horos
BFBernd Fischer
Bernd Fischer
ACAlfredo Castello
Alfredo Castello
KEKatrin Eichelbaum
Katrin Eichelbaum
MHMatthias W. Hentze
Matthias W. Hentze
RNA-binding proteins (RBPs) exert a broad range of biological functions. To explore the scope of RBPs across eukaryotic evolution, we determined the in vivo RBP repertoire of the yeast Saccharomyces cerevisiae and identified 678 RBPs from yeast and additionally 729 RBPs from human hepatocytic HuH-7 cells. Combined analyses of these and recently published data sets define the core RBP repertoire conserved from yeast to man. Conserved RBPs harbour defined repetitive motifs within disordered regions, which display striking evolutionary expansion. Only 60% of yeast and 73% of the human RBPs have functions assigned to RNA biology or structural motifs known to convey RNA binding, and many intensively studied proteins surprisingly emerge as RBPs (termed ‘enigmRBPs’), including almost all glycolytic enzymes, pointing to emerging connections between gene regulation and metabolism. Analyses of the mitochondrial hydroxysteroid dehydrogenase (HSD17B10) uncover the RNA-binding specificity of an enigmRBP.

1 February 2019 in Cell
Verified
Journal Article
Closed access
RHRastislav Horos
Rastislav Horos
MBMagdalena Büscher
Magdalena Büscher
RKRozemarijn Kleinendorst
Rozemarijn Kleinendorst
AAAnne-Marie Alleaume
Anne-Marie Alleaume
ATAbul K. Tarafder
Abul K. Tarafder
MHMatthias W. Hentze
Matthias W. Hentze

23 October 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
JPJoel I. Perez-Perri
Joel I. Perez-Perri
BRBirgit Rogell
Birgit Rogell
TSThomas Schwarzl
Thomas Schwarzl
Frank SteinFrank Stein
Frank Stein
YZYang Zhou
Yang Zhou
MHMatthias W. Hentze
Matthias W. Hentze
Following the realization that eukaryotic RNA-binding proteomes are substantially larger than anticipated, we must now understand their detailed composition and dynamics. Methods such as RNA interactome capture (RIC) have begun to address this need. However, limitations of RIC have been reported. Here we describe enhanced RNA interactome capture (eRIC), a method based on the use of an LNA-modified capture probe, which yields numerous advantages including greater specificity and increased signal-to-noise ratios compared to existing methods. In Jurkat cells, eRIC reduces the rRNA and DNA contamination by >10-fold compared to RIC and increases the detection of RNA-binding proteins. Due to its low background, eRIC also empowers comparative analyses of changes of RNA-bound proteomes missed by RIC. For example, in cells treated with dimethyloxalylglycine, which inhibits RNA demethylases, eRIC identifies m6A-responsive RNA-binding proteins that escape RIC. eRIC will facilitate the unbiased characterization of RBP dynamics in response to biological and pharmacological cues.

15 June 2022 in Molecular Cell
Verified
Journal Article
Open access
IHIna Huppertz
Ina Huppertz
JPJoel I. Perez-Perri
Joel I. Perez-Perri
PMPanagiotis Mantas
Panagiotis Mantas
TSThileepan Sekaran
Thileepan Sekaran
TSThomas Schwarzl
Thomas Schwarzl
MHMatthias W. Hentze
Matthias W. Hentze
Differentiating stem cells must coordinate their metabolism and fate trajectories. Here, we report that the catalytic activity of the glycolytic enzyme Enolase 1 (ENO1) is directly regulated by RNAs leading to metabolic rewiring in mouse embryonic stem cells (mESCs). We identify RNA ligands that specifically inhibit ENO1's enzymatic activity in vitro and diminish glycolysis in cultured human cells and mESCs. Pharmacological inhibition or RNAi-mediated depletion of the protein deacetylase SIRT2 increases ENO1's acetylation and enhances its RNA binding. Similarly, induction of mESC differentiation leads to increased ENO1 acetylation, enhanced RNA binding, and inhibition of glycolysis. Stem cells expressing mutant forms of ENO1 that escape or hyper-activate this regulation display impaired germ layer differentiation. Our findings uncover acetylation-driven riboregulation of ENO1 as a physiological mechanism of glycolytic control and of the regulation of stem cell differentiation. Riboregulation may represent a more widespread principle of biological control.